Category - Pharma Industry News
AZ/Oxford University vaccine shows 82.4% efficacy with extended dosing schedule
COVID-19 antibodies ‘last at least six months’ in most people
BMS’ deucravacitinib beats Otezla in psoriasis study
NICE green light for GSK’s Nucala
Patients gain early access to Pfizer’s atopic dermatitis drug
New analysis backs safety, efficacy of AZ/Oxford COVID-19 jab
FDA approves new indication for Adamas’ Gocovri in Parkinson’s disease
UK vaccinations top nine million as concerns rise over South Africa variant